Sign In
Buy CDXC
$7.87
+0 (+0%)
At Close: Jun 17, 2025
Recap: ChromaDex Q3 Earnings
04:41pm, Wednesday, 03'rd Nov 2021
ChromaDex (NASDAQ:CDXC) reported its Q3 earnings results on Wednesday, November 3, 2021 at 04:02 PM. Here's what investors need to know about the announcement.
LOS ANGELES--(BUSINESS WIRE)---- $CDXC #ataxia--ChromaDex Corp. (NASDAQ:CDXC) today announced promising findings from a first-of-its-kind clinical study published in the peer-reviewed journal, Movemen
ChromaDex to Report Third Quarter 2021 Financial Results on Wednesday, Nov. 3, 2021
06:33am, Wednesday, 13'th Oct 2021
LOS ANGELES--(BUSINESS WIRE)---- $CDXC #earnings--ChromaDex Corp. (NASDAQ:CDXC) announced that it will hold a conference call on Wednesday, Nov. 3, 2021 at 4:30 p.m. ET to discuss its financial result
ChromaDex Comments on Jury Award Against Elysium Health and Reiterates Plans for Growth
06:33am, Friday, 01'st Oct 2021
LOS ANGELES--(BUSINESS WIRE)---- $CDXC #cdxc--ChromaDex Corp. (NASDAQ:CDXC) today announced that a jury in the United States District Court for the Central District of California found that Elysium He
ChromaDex Partners with Sinopharm Xingsha for Cross-Border Sales of Tru Niagen® into Mainland China
06:37am, Wednesday, 29'th Sep 2021
LOS ANGELES--(BUSINESS WIRE)---- $CDXC #ChinaCrossBorder--ChromaDex Corp. (NASDAQ: CDXC) announced today a partnership with Sinopharm Xingsha Pharmaceuticals (Xiamen) Co., Ltd. (“Sinopharm Xingsha�
ChromaDex Shares Preclinical Research Findings and Scientific Initiations from the ChromaDex External Research Program (CERP™)
06:33am, Monday, 20'th Sep 2021
LOS ANGELES--(BUSINESS WIRE)---- $CDXC #nicotinamideriboside--ChromaDex Corp. (NASDAQ:CDXC) today announced findings from recently published preclinical studies, as well as recently registered clinica
Why ChromaDex Stock Is Sinking Today
04:16pm, Wednesday, 15'th Sep 2021
The company lost a key patent infringement lawsuit but plans to appeal the court decision.
CDXC Stock: Why It Significantly Dropped Today
09:21am, Wednesday, 15'th Sep 2021
The stock price of ChromaDex Corp. (NASDAQ: CDXC) dropped over 20% pre-market today. This is why it happened.
Why Are ChromaDex Shares Trading Lower On Wednesday?
08:37am, Wednesday, 15'th Sep 2021
ChromaDex Corp (NASDAQ: CDXC) dropped over 20% during the premarket despite its announcement over plans to appeal a court ruling issued by the U.S. District Court for the District of Delaware in a
ChromaDex Continues to Defend Strong Intellectual Property Portfolio and Plans to Appeal Judge's Ruling in Patent Infringement Lawsuit
06:30am, Wednesday, 15'th Sep 2021
LOS ANGELES--(BUSINESS WIRE)--ChromaDex Corp. (NASDAQ:CDXC) issued the following statement: ChromaDex announced today plans to appeal a September 14 decision granting a Motion for Summary Judgment (MS
ChromaDex Corporation (CDXC) CEO Rob Fried on Q2 2021 Results - Earnings Call Transcript
11:10pm, Tuesday, 03'rd Aug 2021
ChromaDex Corporation (CDXC) CEO Rob Fried on Q2 2021 Results - Earnings Call Transcript
ChromaDex (CDXC) Reports Q2 Loss, Tops Revenue Estimates
07:04pm, Tuesday, 03'rd Aug 2021
ChromaDex (CDXC) delivered earnings and revenue surprises of 11.11% and 7.14%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
ChromaDex to Report Second Quarter 2021 Financial Results on Tuesday, August 3, 2021
06:33am, Tuesday, 20'th Jul 2021
LOS ANGELES--(BUSINESS WIRE)---- $CDXC #earnings--ChromaDex Corp. (NASDAQ:CDXC) announced that it will hold a conference call on Tues., August 3, 2021 at 4:30 p.m. ET to discuss its financial results
ChromaDex Shares Research Findings from the ChromaDex External Research Program (CERP™)
06:33am, Wednesday, 16'th Jun 2021
LOS ANGELES--(BUSINESS WIRE)---- $CDXC #healthyaging--ChromaDex Corp. (NASDAQ:CDXC) today announced the results of four recently published preclinical studies, highlighting new findings for its patent
Why ChromaDex Stock Is Jumping Today
12:19pm, Monday, 07'th Jun 2021
The company's flagship product was launched in Walmart stores across the U.S.
